ID Source | ID |
---|---|
PubMed CID | 10573320 |
CHEMBL ID | 478005 |
SCHEMBL ID | 4753065 |
MeSH ID | M0542004 |
Synonym |
---|
ceratinamine |
CHEMBL478005 |
SCHEMBL4753065 |
n-[3-[4-(2-aminoethyl)-2,6-dibromophenoxy]propyl]-1-cyanoformamide |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID200942 | Tested for growth inhibition against human SF-268 CNS cancer cell line at 100 uM | 2002 | Bioorganic & medicinal chemistry letters, Mar-11, Volume: 12, Issue:5 ISSN: 0960-894X | Cytotoxic, antifouling bromotyramines: a synthetic study on simple marine natural products and Their analogues. |
AID767736 | Cytotoxicity against human HCT15 cells after 48 hrs by sulforhodamine B assay | 2013 | Journal of natural products, Sep-27, Volume: 76, Issue:9 ISSN: 1520-6025 | Cytotoxic psammaplysin analogues from a Suberea sp. marine sponge and the role of the spirooxepinisoxazoline in their activity. |
AID767733 | Cytotoxicity against human MDA-MB-231 cells after 48 hrs by sulforhodamine B assay | 2013 | Journal of natural products, Sep-27, Volume: 76, Issue:9 ISSN: 1520-6025 | Cytotoxic psammaplysin analogues from a Suberea sp. marine sponge and the role of the spirooxepinisoxazoline in their activity. |
AID143033 | Tested for growth inhibition against human NCI-H460 lung cancer cell line at 100 uM | 2002 | Bioorganic & medicinal chemistry letters, Mar-11, Volume: 12, Issue:5 ISSN: 0960-894X | Cytotoxic, antifouling bromotyramines: a synthetic study on simple marine natural products and Their analogues. |
AID103883 | Tested for growth inhibition against human MCF-7 breast cancer cell line at 100 uM | 2002 | Bioorganic & medicinal chemistry letters, Mar-11, Volume: 12, Issue:5 ISSN: 0960-894X | Cytotoxic, antifouling bromotyramines: a synthetic study on simple marine natural products and Their analogues. |
AID767734 | Cytotoxicity against human ACHN cells after 48 hrs by sulforhodamine B assay | 2013 | Journal of natural products, Sep-27, Volume: 76, Issue:9 ISSN: 1520-6025 | Cytotoxic psammaplysin analogues from a Suberea sp. marine sponge and the role of the spirooxepinisoxazoline in their activity. |
AID767731 | Cytotoxicity against human NCI-H23 cells after 48 hrs by sulforhodamine B assay | 2013 | Journal of natural products, Sep-27, Volume: 76, Issue:9 ISSN: 1520-6025 | Cytotoxic psammaplysin analogues from a Suberea sp. marine sponge and the role of the spirooxepinisoxazoline in their activity. |
AID767732 | Cytotoxicity against human NUGC3 cells after 48 hrs by sulforhodamine B assay | 2013 | Journal of natural products, Sep-27, Volume: 76, Issue:9 ISSN: 1520-6025 | Cytotoxic psammaplysin analogues from a Suberea sp. marine sponge and the role of the spirooxepinisoxazoline in their activity. |
AID341034 | Cytotoxicity against human HCT116 cells at 10 ug/mL by MTT assay | 2008 | Journal of natural products, Aug, Volume: 71, Issue:8 ISSN: 1520-6025 | Bioactive brominated metabolites from the Red Sea sponge Pseudoceratina arabica. |
AID767735 | Cytotoxicity against human PC3 cells after 48 hrs by sulforhodamine B assay | 2013 | Journal of natural products, Sep-27, Volume: 76, Issue:9 ISSN: 1520-6025 | Cytotoxic psammaplysin analogues from a Suberea sp. marine sponge and the role of the spirooxepinisoxazoline in their activity. |
AID380813 | Induction of apoptosis in human U937 cells | 1999 | Journal of natural products, Jul, Volume: 62, Issue:7 ISSN: 0163-3864 | 7-Hydroxyceratinamine, a new cyanoformamide-containing metabolite from a sponge, Aplysinella sp. |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
psammaplysin a | 2008 | 2008 | 16.0 | high | 0 | 0 | 0 | 1 | 0 | 0 |
Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
tyrosine | amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; proteinogenic amino acid; tyrosine | EC 1.3.1.43 (arogenate dehydrogenase) inhibitor; fundamental metabolite; micronutrient; nutraceutical | 2013 | 2013 | 11.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 | |
oxazolidin-2-one | carbamate ester; oxazolidinone | metabolite | 2009 | 2009 | 15.0 | medium | 0 | 0 | 0 | 1 | 0 | 0 | |
organophosphonates | divalent inorganic anion; phosphite ion | 2009 | 2009 | 15.0 | medium | 0 | 0 | 0 | 1 | 0 | 0 | ||
psammaplysin f | 2013 | 2013 | 11.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
---|